Soligenix ricin-anthrax vaccine combo induces protective immunity
This article was originally published in Scrip
Executive Summary
Shares of Soligenix got a 5% boost in morning trading on 29 December after researchers reported data that showed the combination of the company's anti-ricin vaccine RiVax plus its anti-anthrax vaccine VeloThrax induced protective immunity to both toxins.